Medpace director plans 3,858-share stock sale

Medpace Holdings, Inc. (MEDP) received a notice under Rule 144 that director Robert O. Kraft plans to sell restricted common stock.

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) received a notice under Rule 144 that director Robert O. Kraft plans to sell restricted common stock. The planned sale covers 3,858 shares of common stock through Fidelity Brokerage Services LLC on or about August 26, 2026, in connection with a stock option exercise. The shares are listed on NASDAQ. The notice is signed on Kraft’s behalf by Fidelity as attorney-in-fact.

Key Figures

Shares to be sold: 3,858 shares of common stock Aggregate market value: 2,383,522.47 Shares outstanding: 27,911,655 shares +1 more

4 metrics

Shares to be sold 3,858 shares of common stock Planned Rule 144 sale related to stock option exercise

Aggregate market value 2,383,522.47 Aggregate market value of 3,858 shares to be sold

Shares outstanding 27,911,655 shares Number of common shares outstanding referenced in the notice

Approximate sale date 08/26/2026 Planned date for Rule 144 sale

Key Terms

Rule 144, aggregate market value, stock option exercise, attorney-in-fact

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 2383522.47 | 27911655 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

stock option exercise financial

"Common | 08/26/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

attorney-in-fact regulatory

"as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert O. Kraft"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Medpace Holdings, Inc. (MEDP)?

The filing discloses that director Robert O. Kraft intends to sell 3,858 shares of Medpace Holdings, Inc. common stock under Rule 144, in connection with a stock option exercise, through Fidelity Brokerage Services LLC, with an expected sale date of August 26, 2026.

How many MEDP shares are covered by Robert O. Kraft’s planned Rule 144 sale?

Robert O. Kraft’s planned Rule 144 transaction covers 3,858 shares of Medpace Holdings, Inc. common stock, to be sold in connection with a stock option exercise through Fidelity Brokerage Services LLC.

What is the aggregate market value reported for the MEDP shares in this Form 144?

The notice reports an aggregate market value of 2,383,522.47 for the 3,858 shares of Medpace Holdings, Inc. common stock subject to the planned Rule 144 sale.

When is the planned sale of Medpace (MEDP) shares expected to occur under this Form 144?

The planned Rule 144 sale of 3,858 MEDP shares related to a stock option exercise is indicated to occur on or about August 26, 2026.

Who is executing the planned Form 144 sale for Medpace (MEDP) director Robert O. Kraft?

The planned sale will be executed through Fidelity Brokerage Services LLC. The Form 144 is signed by Daniel Tucci as a duly authorized representative of Fidelity, acting as attorney-in-fact for Robert O. Kraft.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/26/2026 - 02:43 PM Accepted by SEC EDGAR 08/26/2026 - 02:43 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001558592
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medpace Holdings, Inc.
SEC File Number	001-37856
Address of Issuer	5375 MEDPACE WAY CINCINNATI OHIO 45227
Phone	(513) 579-9911
Name of Person for Whose Account the Securities are To Be Sold	Kraft Robert O.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3858	2383522.47	27911655	08/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/26/2026	Stock Option Exercise	Issuer			3858	08/26/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/26/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Robert O. Kraft
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)